Xenopatients show the need for precision medicine approach to chemotherapy in ovarian cancer.
about
Protein tyrosine phosphatase PTPN3 promotes drug resistance and stem cell-like characteristics in ovarian cancerComparison of Clinical Features and Outcomes in Epithelial Ovarian Cancer according to Tumorigenicity in Patient-Derived Xenograft Models.The Generation and Application of Patient-Derived Xenograft Model for Cancer Research.
P2860
Xenopatients show the need for precision medicine approach to chemotherapy in ovarian cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 March 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Xenopatients show the need for ...... hemotherapy in ovarian cancer.
@en
Xenopatients show the need for ...... hemotherapy in ovarian cancer.
@nl
type
label
Xenopatients show the need for ...... hemotherapy in ovarian cancer.
@en
Xenopatients show the need for ...... hemotherapy in ovarian cancer.
@nl
prefLabel
Xenopatients show the need for ...... hemotherapy in ovarian cancer.
@en
Xenopatients show the need for ...... hemotherapy in ovarian cancer.
@nl
P2093
P2860
P50
P356
P1433
P1476
Xenopatients show the need for ...... chemotherapy in ovarian cancer
@en
P2093
Dionyssios Katsaros
Gloria Mittica
Jessica Erriquez
Marco Vaira
Maria Stella Scalzo
Michele De Simone
P2860
P304
26181-26191
P356
10.18632/ONCOTARGET.8325
P407
P577
2016-05-01T00:00:00Z